Do Endocrinopathies Cause Changes in Transverse Carpal Ligament Thickness and Carpal Tunnel Area in Carpal Tunnel Syndrome?

Numan KARAARSLAN, (Tekirdağ Namık Kemal Üniversitesi, Tıp Fakültesi, Nöroşirürji Anabilim Dalı, Tekirdağ, Türkiye)
Abdullah Talha ŞİMŞEK, (Tekirdağ Namık Kemal Üniversitesi, Tıp Fakültesi, Nöroşirürji Anabilim Dalı, Tekirdağ, Türkiye)
Kadir ÖZNAM, (İstanbul Medipol Üniversitesi, Tıp Fakültesi, Ortopedi ve Travmatoloji Anabilim Dalı, İstanbul, Türkiye)
Ahmet Murat BÜLBÜL (İstanbul Medipol Üniversitesi, Tıp Fakültesi, Ortopedi ve Travmatoloji Anabilim Dalı, İstanbul, Türkiye)
European Archives of Medical Research
83 0
Yıl: 2020 Cilt: 36 Sayı: 1 Sayfa Aralığı: 45 - 51 Metin Dili: İngilizce DOI: 10.4274/eamr.galenos.2019.35762 İndeks Tarihi: 20-10-2020

Do Endocrinopathies Cause Changes in Transverse Carpal Ligament Thickness and Carpal Tunnel Area in Carpal Tunnel Syndrome?

Öz:
Objective: The purpose of this study was to investigate the effect of transverse carpal ligament (TCL) thickness and the size of carpal tunnelarea on clinical findings and electrophysiological changes through the wrist magnetic resonance imaging (MRI).Methods: In this prospective study, the thickness of the TCL and the carpal tunnel areas of preoperative cases diagnosed with carpal tunnelsyndrome (CTS) were measured via wrist MRI results. The effect of TCL thickness and carpal tunnel area on endocrinopathies such as diabetesmellitus (DM) and hypothyroidism and the effect of these variables on clinical findings and electrophysiologic changes were evaluated in thelight of the literature.Results: TCL thickness and carpal tunnel area were not statistically significant among DM, hypothyroidism and electrophysiological changes(p>0.05).Conclusion: This study include one of the limited researches comparing the carpal tunnel area and TKL thickness in cases with and withoutendocrinopathy CTS. However, there is a need for further researches that have a greater number of cases, including multi-centered, differentwinged people.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Netscher D, Mosharrafa A, Lee M, Polsen C, Choi H, Steadman AK, et al. Transversecarpalligament: its effect on flexor tendon excursion, morphologic changes of thecarpal canal, and on pinch and grip strengths after open carpal tunnel release. Plast Reconstr Surg 1997;100:636-42.
  • 2. Schoth F, Kraemer N, Niendorf T, Hohl C, Gunther RW, Krombach GA. Comparison of image quality in magnetic resonance imaging of the knee at 1.5 and 3.0 Tesla using 32-channel receiver coils. Eur Radiol 2008;18:2258-64.
  • 3. Kang HJ, Jung SH, Yoon HK, Hahn SB, Kim SJ. Carpal tunnel syndrome caused by space occupying lesions. Yonsei Med J 2009;50:257-61.
  • 4. Gray SN, Puchalski SM, Galuppo LD. Computed tomographic arthrography of the intercarpal ligaments of the equine carpus. Vet Radiol Ultrasound 2013;54:245-52.
  • 5. Nazem MN, Sajjadian SM. Anatomicaltransversemagnetic resonance imaging study of ligaments in palmar surface of metacarpus in Miniature donkey: identification of a new ligament. Folia Morphol (Warsz) 2017;76:110-6.
  • 6. Ikeda M, Okada M, Toyama M, Uemura T, Takamatsu K, Nakamura H. Comparison of Median Nerve Cross-sectional Area on 3-T MRI in Patients With Carpal Tunnel Syndrome. Orthopedics 2017;40:e77-e81.
  • 7. Yaşar Şirin D, Yılmaz İ, İsyar M, Öznam K, Mahiroğulları M. Does leukocyte-poor or leukocyte-rich platelet-rich plasma applied with biopolymers have superiority to conventional platelet-rich plasma applications on chondrocyte proliferation? Eklem Hastalik Cerrahisi 2017;28:142-51.
  • 8. Komur B, Akyuva Y, Karaslan N, Isyar M, Gumustas SA, Yilmaz I, et al. Can a Biodegradable Implanted Bilayered Drug Delivery System Loaded with BMP-2/BMP-12 Take an Effective Role in the Biological Repair Process of Bone-Tendon Injuries? A Preliminary Report. J Pharm (Cairo) 2017;2017:7457865.
  • 9. Oznam K, Sirin DY, Yilmaz I, Kaya YE, Isyar M, Gumustas SA, et al. Iopromide- and gadopentetic acid-derived preparates used in MR arthrography may be harmful to chondrocytes. J Orthop Surg Res 2017;12:98.
  • 10. Gumustas F, Yilmaz I, Yulaf Y, Gokce S, Sabuncuoglu O. Empathy and Facial Expression Recognition in Children With and Without AttentionDeficit/Hyperactivity Disorder: EffeKTS of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol 2017;27:433-9.
  • 11. Gumustas F, Yilmaz I, Sirin DY, Gumustas SA, Batmaz AG, Isyar M, et al. Chondrocyte proliferation, viability and differentiation is declined following administration of methylphenidate utilized for the treatment of attention-deficit/hyperactivity disorder. Hum Exp Toxicol 2017;36:981-92.
  • 12. Bisson MA, Beckett KS, McGrouther DA, Grobbelaar AO, Mudera V. Transforming growth factor-beta1 stimulation enhances Dupuytren’s fibroblast contraction in response to uniaxial mechanical load within a 3-dimensional collagen gel. J Hand Surg Am 2009;34:1102-10.
  • 13. Frieboes LR, Palispis WA, Gupta R. Nerve compression activates selective nociceptive pathways and upregulates peripheral sodium channel expression in Schwann cells. J Orthop Res 2010;28:753-61.
  • 14. Gokce A, Yilmaz I, Bircan R, Tonbul M, Gokay NS, Gokce C. Synergistic Effect of TGF-β1 And BMP-7 on Chondrogenesis and Extracellular Matrix Synthesis: An In Vitro Study. Open Orthop J 2012;6:406-13.
  • 15. 15.Gökçe A, Yılmaz I, Gökay NS, Can L, Gökçe C. Does insulin, transferrin and selenous acid preparation effect chondrocyte proliferation? Acta Orthop Traumatol Turc 2014;48:313-9.
  • 16. Yilmaz I, Gokay NS, Gokce A, Tonbul M, Gokce C. A Novel designed chitosan based hydrogel which is capable of consecutively controlled release of TGF-Beta 1 and BMP-7. Turkiye Klinikleri J Med Sci 2013;33:18- 32.
  • 17. Yilmaz I, Gokay NS, Bircan R, Saracoglu GV, Dervisoglu S, Gokce A. How different methodologies of harvesting and analysing the samples affect the test results in determining joint mediators. Arthritis 2013;2013:631959.
  • 18. Isyar M, Yilmaz I, Sirin DY, Yalcin S, Guler O, Mahirogullari M. A practical way to prepare primer human chondrocyte culture. J Orthop 2016;13:162-7.
  • 19. Isyar M, Bilir B, Yilmaz I, Cakmak S, Sirin DY, Guzelant AY, et al. Are biological agents toxic to human chondrocytes and osteocytes? J Orthop Surg Res 2015;10:118.
  • 20. Li Pi Shan R, Nicolle M, Chan M, White C, Winston P, et al. Electrodiagnostic Testing and Treatment for Carpal Tunnel Syndrome in Canada. Can J Neurol Sci 2016;43:178-82.
  • 21. Chen P, Maklad N, Redwine M, Zelitt D. Dynamic high-resolution sonography of the carpal tunnel. AJR Am J Roentgenol 1997;168:533-7.
  • 22. Szabo RM, Madison M. Carpal tunnel syndrome. Orthop Clin North Am 1992;23:103-9.
  • 23. Tanaka T, Yoshioka H, Ueno T, Shindo M, Ochiai N. Comparison between high-resolution MRI with a microscopy coil and arthroscopy in triangular fibrocartilage complex injury. J Hand Surg Am 2006;31:1308-14.
  • 24. Hayes EP, Carney K, Wolf J, Smith JM, Akelman E. Carpal Tunnel Syndrome. In: Mackin EJ, Callahan AD, Skirven TM, Schneider LH, Osterman AL: Rehabilitation of the Hand and Upper Extremity. 5th edition. St. Louis, CV Mosby; 2002, 643-59.
  • 25. Fornage BD, Schernberg FL, Rifkin MD. Ultrasound examination of the hand. Radiology 1985;155:785-8.
  • 26. Finsen VV, Russwurm H. Neurophysiology not required before surgery for typical carpal tunnel syndrome J Hand Surg [Br] 2001;26:61-4.
  • 27. Kantarci F, Ustabasioglu FE, Delil S, Olgun DC, Korkmazer B, Dikici AS, et al. Median nerve stiffness measurement by shear wave elastography: a potential sonographic method in the diagnosis of carpal tunnel syndrome. Eur Radiol 2014;24:434-40.
  • 28. Visser LH, Ngo Q, Groeneweg SJ, Brekelmans G. Long term effect of local corticosteroid injection for carpal tunnel syndrome: a relation with electrodiagnostic severity. Clin Neurophysiol 2012;123:838-41.
  • 29. Schmid, Annina B. Strudwick MW, Little M, Coppieters MW. Effect of splinting and exercise on intraneural edema of the median nerve in carpal tunnel syndrome-an MRI study to reveal therapeutic mechanisms. J Orthop Res 2012;30:1343-50.
  • 30. de Krom MC, Kester AD, Knipschild PG, Spaans F. Risk factors for carpal tunnel syndrome. Am J Epidemiol 1990;132:1102-10.
APA Karaarslan N, şimşek a, OZNAM K, bülbül a (2020). Do Endocrinopathies Cause Changes in Transverse Carpal Ligament Thickness and Carpal Tunnel Area in Carpal Tunnel Syndrome?. , 45 - 51. 10.4274/eamr.galenos.2019.35762
Chicago Karaarslan Numan,şimşek abdullah talha,OZNAM Kadir,bülbül ahmet Do Endocrinopathies Cause Changes in Transverse Carpal Ligament Thickness and Carpal Tunnel Area in Carpal Tunnel Syndrome?. (2020): 45 - 51. 10.4274/eamr.galenos.2019.35762
MLA Karaarslan Numan,şimşek abdullah talha,OZNAM Kadir,bülbül ahmet Do Endocrinopathies Cause Changes in Transverse Carpal Ligament Thickness and Carpal Tunnel Area in Carpal Tunnel Syndrome?. , 2020, ss.45 - 51. 10.4274/eamr.galenos.2019.35762
AMA Karaarslan N,şimşek a,OZNAM K,bülbül a Do Endocrinopathies Cause Changes in Transverse Carpal Ligament Thickness and Carpal Tunnel Area in Carpal Tunnel Syndrome?. . 2020; 45 - 51. 10.4274/eamr.galenos.2019.35762
Vancouver Karaarslan N,şimşek a,OZNAM K,bülbül a Do Endocrinopathies Cause Changes in Transverse Carpal Ligament Thickness and Carpal Tunnel Area in Carpal Tunnel Syndrome?. . 2020; 45 - 51. 10.4274/eamr.galenos.2019.35762
IEEE Karaarslan N,şimşek a,OZNAM K,bülbül a "Do Endocrinopathies Cause Changes in Transverse Carpal Ligament Thickness and Carpal Tunnel Area in Carpal Tunnel Syndrome?." , ss.45 - 51, 2020. 10.4274/eamr.galenos.2019.35762
ISNAD Karaarslan, Numan vd. "Do Endocrinopathies Cause Changes in Transverse Carpal Ligament Thickness and Carpal Tunnel Area in Carpal Tunnel Syndrome?". (2020), 45-51. https://doi.org/10.4274/eamr.galenos.2019.35762
APA Karaarslan N, şimşek a, OZNAM K, bülbül a (2020). Do Endocrinopathies Cause Changes in Transverse Carpal Ligament Thickness and Carpal Tunnel Area in Carpal Tunnel Syndrome?. European Archives of Medical Research, 36(1), 45 - 51. 10.4274/eamr.galenos.2019.35762
Chicago Karaarslan Numan,şimşek abdullah talha,OZNAM Kadir,bülbül ahmet Do Endocrinopathies Cause Changes in Transverse Carpal Ligament Thickness and Carpal Tunnel Area in Carpal Tunnel Syndrome?. European Archives of Medical Research 36, no.1 (2020): 45 - 51. 10.4274/eamr.galenos.2019.35762
MLA Karaarslan Numan,şimşek abdullah talha,OZNAM Kadir,bülbül ahmet Do Endocrinopathies Cause Changes in Transverse Carpal Ligament Thickness and Carpal Tunnel Area in Carpal Tunnel Syndrome?. European Archives of Medical Research, vol.36, no.1, 2020, ss.45 - 51. 10.4274/eamr.galenos.2019.35762
AMA Karaarslan N,şimşek a,OZNAM K,bülbül a Do Endocrinopathies Cause Changes in Transverse Carpal Ligament Thickness and Carpal Tunnel Area in Carpal Tunnel Syndrome?. European Archives of Medical Research. 2020; 36(1): 45 - 51. 10.4274/eamr.galenos.2019.35762
Vancouver Karaarslan N,şimşek a,OZNAM K,bülbül a Do Endocrinopathies Cause Changes in Transverse Carpal Ligament Thickness and Carpal Tunnel Area in Carpal Tunnel Syndrome?. European Archives of Medical Research. 2020; 36(1): 45 - 51. 10.4274/eamr.galenos.2019.35762
IEEE Karaarslan N,şimşek a,OZNAM K,bülbül a "Do Endocrinopathies Cause Changes in Transverse Carpal Ligament Thickness and Carpal Tunnel Area in Carpal Tunnel Syndrome?." European Archives of Medical Research, 36, ss.45 - 51, 2020. 10.4274/eamr.galenos.2019.35762
ISNAD Karaarslan, Numan vd. "Do Endocrinopathies Cause Changes in Transverse Carpal Ligament Thickness and Carpal Tunnel Area in Carpal Tunnel Syndrome?". European Archives of Medical Research 36/1 (2020), 45-51. https://doi.org/10.4274/eamr.galenos.2019.35762
Sayfa Oluşturulma Tarihi
23-04-2024 14:10

İLETİŞİM

TÜBİTAK ULAKBİM TR Dizin

Yüzüncüyıl, İşçi Blokları Mahallesi

Muhsin Yazıcıoğlu Caddesi No:51/C

06530 Çankaya / ANKARA +90 (312) 298 92 00

trdizin@tubitak.gov.tr

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © Tüm Hakları Saklıdır. Gizlilik Politikası Kullanım Şartları